Key Sterile Injectable Drugs Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Novartis AG
- Roche Holding AG
- Sanofi
- Johnson & Johnson
- Merck & Co.
- GlaxoSmithKline
- Eli Lilly and Company
- Takeda Pharmaceutical
- Bristol-Myers Squibb
- Gilead Sciences
- Fresenius Kabi
- Baxter International
- Hikma Pharmaceuticals
- Sun Pharmaceutical
- Biocon
- Samsung Biologics
- Pharmaniaga
The highly competitive market of sterile injectable drug market is led by the top five key players that hold approximately 52% of the market share. The leading strategies that delivered a competitive edge include biosimilar expansion, oncology focus, expansion in the emerging market, collaboration, and many more. For instance, Pfizer and Novartis focus on product innovation and have expanded into biosimilar expansion. Roche and Merck focused on the oncology market niche and introduced products like Keytruda and Herceptin. Sun Pharma controlled the cost of production and expanded its business in the emerging market of India. A collaboration strategy is implemented by AstraZeneca with Samsung Biologics to promote collaborative manufacturing to achieve a competitive edge.
Here is a list of key players operating in the global market:
